Taking people in AustriaNo phase
Whether changing the needle between lymph nodes matters in lung cancer staging by EBUS
Compares changing versus keeping the needle between lymph nodes during EBUS staging in lung cancer.
Plain-language title generated from the registry record
Registry title: Discrimination of N2a and N2b by EBUS-TBNA: is a Change of the Needle Necessary?
Key facts
- Where
- Vienna, AustriaSee the site
Where in Austria
- Medical University of ViennaVienna, AustriaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Vienna
- Trial code
- NCT07418450
- Record updated
- 18 February 2026
- Original description
During EBUS staging in patients with mediastinal lymphadenopathy, it is planned to perform a first round of staging with change of the needle between all lymph nodes and a second round of staging without change of the needle.Read full original descriptionShow less
Discrimination of N2a and N2b by EBUS-TBNA: is a Needle Change Necessary? - a Prospective Pilot Study
During EBUS staging in patients with mediastinal lymphadenopathy, it is planned to perform a first round of staging with change of the needle between all lymph nodes and a second round of staging without change of the needle.
Inclusion: Pulmonary lesion suspicious for lung cancer or histologically confirmed lung cancer; indication for mediastinal staging.
Exclusion: -.